The Indian perspective of COVID-19 outbreak

The emerging infection of COVID-19 was initiated from Wuhan, China, have been spread to more than 210 countries around the globe including India. The mortality rate of COVID-19 in India is almost half of the global rate. In India, the initial outbreaks started in the regions, which are directly linked to the affected area via trade/travel. In expert opinion, the number of COVID-19 cases could be more but diagnostic rates of India are very low as compared with other countries. The majority of the confirmed cases were linked to other countries; therefore all tourist visas were suspended and ban the entry from effected parts to reduce the chance of infections. The clinical symptoms of COVID-19 are very similar to influenza and other respiratory viruses. Similar observations were noted in Indian patients also. The patients come with unexplained upper respiratory viral infection. The majority of patients have symptoms of fever, cough, sore throat, nasal congestion, malaise, and headache. The elderly and other immunocompromised patients have more and severe atypical symptoms. In India, the suspected patients are select as per country and/or WHO guidelines; the appropriate samples should be collected in the early phase of infection. The samples should collect after proper wearing of personal protective equipment (PPE). The collected samples should be transported in the virology laboratory in cold conditions. In the virology laboratory, the sample will be processed and standardized assay will be applied for the diagnosis. In India, All the COVID-19 diagnoses done in more than a hundred NABL accredits virology laboratories. COVID-19 is diagnosis by the Real-time RT-PCR by following the WHO protocol and ICMR guidelines. Now, COVID-19 spread in almost every part of India. Therefore, health workers, governments and the public are needed to co-operate national as well as globally to prevent it from further spread. The government should do continuous surveillance, screening the traveler comes from infected areas; develop timely diagnostics, therapeutics, vaccines. To read more- https://link.springer.com/article/10.1007%2Fs13337-020-00587-x

5 Likes

LikeAnswersShare
Informative
Nice post

Cases that would interest you